APA (7th ed.) Citation

Dinh, A., Ropers, J., Duran, C., Davido, B., Deconinck, L., Matt, M., . . . Delcey, V. (2021). Discontinuing β-lactam treatment after 3 days for patients with community-acquired pneumonia in non-critical care wards (PTC): A double-blind, randomised, placebo-controlled, non-inferiority trial. Lancet, 397(10280), 1195. https://doi.org/10.1016/S0140-6736(21)00313-5

Chicago Style (17th ed.) Citation

Dinh, Aurélien, et al. "Discontinuing β-lactam Treatment After 3 Days for Patients with Community-acquired Pneumonia in Non-critical Care Wards (PTC): A Double-blind, Randomised, Placebo-controlled, Non-inferiority Trial." Lancet 397, no. 10280 (2021): 1195. https://doi.org/10.1016/S0140-6736(21)00313-5.

MLA (9th ed.) Citation

Dinh, Aurélien, et al. "Discontinuing β-lactam Treatment After 3 Days for Patients with Community-acquired Pneumonia in Non-critical Care Wards (PTC): A Double-blind, Randomised, Placebo-controlled, Non-inferiority Trial." Lancet, vol. 397, no. 10280, 2021, p. 1195, https://doi.org/10.1016/S0140-6736(21)00313-5.